Hvilken er prisen på Mymetics Corporation (MYMX)

Prisen på Mymetics Corporation (MYMX) er $0.0003

Hva er markedsverdien på Mymetics Corporation (MYMX)

Markedsverdien på Mymetics Corporation (MYMX) er $46.00

Mymetics Corporation (MYMX) Pris og Markedsverdi

Mymetics Corporation is a Swiss biotechnology company dedicated to the research and development of vaccines aimed at preventing infectious and debilitating diseases. Its robust pipeline features several promising vaccine candidates, including those for HIV-1/AIDS, COVID-19, intranasal influenza, respiratory syncytial virus (RSV), malaria, and chikungunya. The company actively collaborates with leading institutions such as the Texas Biomedical Research Institute, the PATH Malaria Vaccine Initiative, and the National Institute of Allergy and Infectious Diseases' Laboratory of Malaria Immunology and Vaccinology, focusing on the development and production of virosome-based vaccine formulations for a malaria transmission-blocking agent. Additionally, Mymetics works with Sanofi Pasteur Biologics, LLC to assess the immunogenicity of influenza vaccines. Founded in 1990, the company was formerly known as ICHOR Corporation, adopting its current name in July 2001, and maintains its base of operations in Epalinges, Switzerland.

Pris på MYMX	Eiendel B	Markedsverdi for B	Resultater
$35,386,959 $46.00	NVDA	$5.426T	+11,795,652,867,586.67%
$28,936,389 $46.00	AAPL	$4.437T	+9,645,463,085,776.28%
$27,049,007 $46.00	GOOG	$4.148T	+9,016,335,562,549.05%
$23,894,665 $46.00	MSFT	$3.664T	+7,964,888,239,874.44%
$18,842,972 $46.00	AMZN	$2.889T	+6,280,990,804,227.84%

Pris på MYMX

Eiendel B

Markedsverdi for B

Resultater

$35,386,959 $46.00